SAN DIEGO, Feb. 6, 2018 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2017 financial results after the Nasdaq market closes on Tuesday, Feb. 13, 2018. Neurocrine will then host a conference call and webcast to…